ibandronate, a bone-resorption inhibitor and electrolyte modifier. ▪ INDICATIONS: This drug is used to prevent and treat osteoporosis. ▪ CONTRAINDICATIONS: Achalasia, esophageal stricture, hypocalcemia, intraarterial administration, renal failure, vitamin D deficiency, and known hypersensitivity to bisphosphonates prohibit the use of this drug. ▪ ADVERSE EFFECTS: Adverse effects of this drug include fever, insomnia, dizziness, headache, hypertension, ocular pain or inflammation, uveitis, constipation, nausea, vomiting, diarrhea, dyspepsia, rash, injection site reaction, bone pain, and myalgia. Common side effects include hypomagnesemia, hypophosphatemia, and hypocalcemia.
